<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03516019</url>
  </required_header>
  <id_info>
    <org_study_id>H-36586</org_study_id>
    <secondary_id>74624</secondary_id>
    <nct_id>NCT03516019</nct_id>
  </id_info>
  <brief_title>eFHS Messaging Trial</brief_title>
  <official_title>Messaging Intervention Trial in the Electronic Framingham Heart Study (eFHS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Robert Wood Johnson Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this research the investigators will develop and test an innovative scalable mobile health
      and digital cardiovascular monitoring system within a longitudinal deeply characterized
      cohort with three components: 1) smartphone application (app) designed to promote adherence,
      integrate digital and mHealth information, and facilitate communication with participants and
      researchers; 2) smartwatch activity monitoring using the Apple iWatch; and 3) home blood
      pressure (BP) monitoring using the Withings blood pressure device.

      The objective of the messaging trial is to test the effect of messaging strategies on
      improving participants' long-term use of and engagement with our selected mobile health
      technologies and on increasing response rate of survey data collection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The research design includes a cohort eFHS Study and an embedded randomized factorial trial
      on a subset of the cohort.

      For the primary e-cohort, the investigators will build a custom mobile app and associated
      web-based platform for use within the Framingham Heart Study (FHS) to digitally collect data,
      validate it against research clinic-collected data, quantify risk factor burden, and perform
      CVD risk prediction. The app development will focus on 1) CVD risk factor data that would
      benefit from more frequent ascertainment than the every four to eight year FHS examination
      cycles; 2) circumstances where in vivo assessment may be superior to clinic-based assessment;
      3) key endpoints of the FHS that are considered FHS landmarks. In addition to the eFHS App,
      participants will be offered wireless devices (Withings BP) and one App (Moves) to measure
      blood pressure, screen for AF, and measure steps per day.

      For the messaging trial, the investigators will conduct a randomized factorial trial phase to
      test the effect of messaging strategies. Participants will be sent a weekly notification
      through the eFHS app. Participants will be randomly allocated to one of 8 groups defined
      according to the following: using personalized reminder messaging vs. standard neutral
      messaging; notification sent on a weekday vs. weekend; notification sent in the morning vs.
      the evening. The three main comparisons will be simultaneously evaluated according to a 2x2x2
      factorial design.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2018</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <intervention_model_description>The research design includes a cohort eFHS Study and an embedded randomized factorial trial on a subset of the cohort.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>eFHS researchers, statistician, research assistant, and clinic staff are masked to intervention assignment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence at 3 months to the weekly BP recording</measure>
    <time_frame>3 months</time_frame>
    <description>proportion of participants who submit their weekly blood pressure measurement at 3 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adherence at 3 months to the weekly HR recording</measure>
    <time_frame>3 months</time_frame>
    <description>proportion of participants who submit their weekly heart rate measurement at 3 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adherence at one month to the weekly BP recording</measure>
    <time_frame>1 month</time_frame>
    <description>proportion of participants who submit their weekly blood pressure measurement at 1 month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence at one month to the weekly HR recording</measure>
    <time_frame>1 month</time_frame>
    <description>proportion of participants who submit their weekly heart rate measurement at 1 month</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Adherence to survey response</measure>
    <time_frame>3 months</time_frame>
    <description>proportion of participants who complete the eFHS survey at 3 months</description>
  </other_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Anticipated">650</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>Weekday am personalized notices</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm receive personalized weekday am notices on Wednesday at 7am.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Weekday pm personalized notices</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm receive a personalized weekday pm notices on Wednesday at 7pm.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Weekend am personalized notices</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm receive a personalized weekend am notices on Saturday at 7am.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Weekend pm personalized notices</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm receive personalized pm notices on Saturday at 7pm.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Weekday am standard notices</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm receive standard weekday notices on Wednesday at 7am.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Weekday pm standard notices</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm receive standard weekday notices on Wednesday at 7pm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Weekend am standard notices</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm receive standard weekend notices on Saturday at 7am</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Weekend pm standard notices</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm receive standard weekend notices on Saturday at 7pm</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>personalized notices</intervention_name>
    <description>The personalized notices take into account if data were received over the previous week, and accordingly encourages the participant to use the device and send her data, or encourages the participant to continue using the device and sending data. A library of personalized notices with alternative motivational content was developed. Each time a notification is sent, it will be drawn at random from the library.</description>
    <arm_group_label>Weekday am personalized notices</arm_group_label>
    <arm_group_label>Weekday pm personalized notices</arm_group_label>
    <arm_group_label>Weekend am personalized notices</arm_group_label>
    <arm_group_label>Weekend pm personalized notices</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard notices</intervention_name>
    <description>The standard notices which are neutral and invite participants to wear the watch daily and to measure their blood pressure weekly.</description>
    <arm_group_label>Weekday am standard notices</arm_group_label>
    <arm_group_label>Weekday pm standard notices</arm_group_label>
    <arm_group_label>Weekend am standard notices</arm_group_label>
    <arm_group_label>Weekend pm standard notices</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>am notices</intervention_name>
    <description>notifications sent at 7 am.</description>
    <arm_group_label>Weekday am personalized notices</arm_group_label>
    <arm_group_label>Weekend am personalized notices</arm_group_label>
    <arm_group_label>Weekday am standard notices</arm_group_label>
    <arm_group_label>Weekend am standard notices</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>pm notices</intervention_name>
    <description>notifications sent at 7 pm.</description>
    <arm_group_label>Weekday pm personalized notices</arm_group_label>
    <arm_group_label>Weekend pm personalized notices</arm_group_label>
    <arm_group_label>Weekday pm standard notices</arm_group_label>
    <arm_group_label>Weekend pm standard notices</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>weekday notices</intervention_name>
    <description>notifications sent on Wednesday</description>
    <arm_group_label>Weekday am personalized notices</arm_group_label>
    <arm_group_label>Weekday pm personalized notices</arm_group_label>
    <arm_group_label>Weekday am standard notices</arm_group_label>
    <arm_group_label>Weekday pm standard notices</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>weekend notices</intervention_name>
    <description>notifications sent on Saturday</description>
    <arm_group_label>Weekend am personalized notices</arm_group_label>
    <arm_group_label>Weekend pm personalized notices</arm_group_label>
    <arm_group_label>Weekend am standard notices</arm_group_label>
    <arm_group_label>Weekend pm standard notices</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for the eFHS study:

          -  Participants of the FHS Third Generation, Omni Group 2, and New Offspring Spouse
             Cohorts attending the in-person examination 3 with access to a smartphone or home
             internet access and English speaking/reading.

        Specifically for the RCT substudy (re: engagement with select mobile health technologies):

          -  English-speaking individual

          -  Owns an iPhone with compatible iOS (version 9 or higher);

          -  Residence in the United States

          -  Provision of permissions for notifications and data sharing with the Research Center

          -  Provision of signed and dated informed consent

        Exclusion Criteria:

          -  Participants who do not meet the inclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joanne Murabito, MD ScM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Framingham Heart Study</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ludovic Trinquart, PhD</last_name>
    <phone>6176385878</phone>
    <email>ludovic@bu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emelia J Benjamin, MD ScM</last_name>
    <phone>617-638-8968</phone>
    <email>emelia@bu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Framingham Heart Study</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joanne Murabito, MC ScM</last_name>
      <phone>508-935-3461</phone>
      <email>murabito@bu.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 24, 2018</study_first_submitted>
  <study_first_submitted_qc>May 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2018</study_first_posted>
  <last_update_submitted>May 3, 2018</last_update_submitted>
  <last_update_submitted_qc>May 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mHealth</keyword>
  <keyword>digital BP monitoring</keyword>
  <keyword>patient provider communication</keyword>
  <keyword>smart watch</keyword>
  <keyword>user engagement</keyword>
  <keyword>population health data</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

